# Maximus, Inc.: Form 10-Q for the period ended Jun 30, 2015

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2015-08-07
- Accepted by EDGAR: Aug 7, 2015, 11:43 ET
- Period: 2015-06-30
- Accession: 0001104659-15-057438
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000110465915057438/a15-11856_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000110465915057438/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-04-01 to 2015-06-30 | $572.3m | us-gaap:Revenues |
| Revenue | 9 months, 2014-10-01 to 2015-06-30 | $1.52bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2015-04-01 to 2015-06-30 | $428.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2014-10-01 to 2015-06-30 | $1.13bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2015-04-01 to 2015-06-30 | $143.8m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2014-10-01 to 2015-06-30 | $387.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2015-04-01 to 2015-06-30 | $67.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2014-10-01 to 2015-06-30 | $178.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2015-04-01 to 2015-06-30 | $71.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2014-10-01 to 2015-06-30 | $198.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2015-04-01 to 2015-06-30 | $28.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2014-10-01 to 2015-06-30 | $75.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-04-01 to 2015-06-30 | $41.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-10-01 to 2015-06-30 | $122.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.62 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2014-10-01 to 2015-06-30 | $1.83 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2014-10-01 to 2015-06-30 | $1.86 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-04-01 to 2015-06-30 | 67,098,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-10-01 to 2015-06-30 | 67,003,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-10-01 to 2015-06-30 | $181.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2014-10-01 to 2015-06-30 | $68.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2014-10-01 to 2015-06-30 | $32.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-06-30 | $81.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-06-30 | $583.1m | us-gaap:AssetsCurrent |
| Total assets | at 2015-06-30 | $1.28bn | us-gaap:Assets |
| Current liabilities | at 2015-06-30 | $366.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-06-30 | $635.2m | us-gaap:Liabilities |
| Long-term debt | at 2015-06-30 | $166.8m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2015-06-30 | $638.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 21,296 characters.

*The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, our Consolidated Financial Statements and related Notes included both herein and in our Annual Report on Form 10-K for the year ended September 30, 2014, filed with the Securities and Exchange Commission on November 17, 2014.*

### Business Overview

We provide business process services (BPS) to government health and human services agencies under our mission of *Helping Government Serve the People.®* We are one of the largest pure-play health and human services BPS providers to governments in the United States, Australia, Canada, the United Kingdom and Saudi Arabia. We use our experience, business process management expertise and advanced technological solutions to help government agencies run efficient and cost-effective programs, improve program accountability and outcomes and enhance the quality of services provided to program beneficiaries.

Over the past five years, our business has grown significantly. We believe this growth has been driven by economic and demographic factors, such as aging populations and increased demand for health care, and the need for governments to operate programs effectively and efficiently. This growth has been driven by reform efforts in the United States, including the Affordable Care Act (ACA), as well as internationally with various programs in Australia and the United Kingdom.

In April 2015, we acquired 100% of Acentia LLC (“Acentia”), a provider of services to the United States Federal Government, and 70% of Remploy, a business providing services to the United Kingdom government. We believe both acquisitions will provide us with the ability to complement our existing services in their respective markets. The results of both entities are included in our results for the three months ended June 30, 2015.

We believe that governments will continue to seek opportunities to enhance existing processes or address new challenges through companies such as MAXIMUS. We believe that a combination of our innovative technical solutions, deep subject matter expertise, stringent adherence to our Standards of Business Conduct and Ethics, robust financial performance and global experience gives existing and future customers the confidence that MAXIMUS can reliably operate their high-profile public health and human services programs.

### Financial Overview

Our results for the three and nine months ended June 30, 2015 have been driven by the following:

- The acquisitions of Acentia and Remploy, which have increased revenue in our Health Services and Human Services Segments, respectively, as well as increasing our working capital, goodwill and intangible asset balances;
- Growth in our Health Services Segment driven by new contracts and expansions to existing work;
- Growth in our Human Services Segment, driven by our international welfare-to-work businesses, offset by the effect of the United States Dollar, whose strength relative to the Australian Dollar and British Pound has reduced our revenues and profits year-over-year;
- Increased investment in our capital infrastructure, which has increased our fixed asset balance and depreciation expense; and
- Borrowings on our credit facility, which have resulted in interest expense.

### Results of Operations

#### Consolidated

The following table sets forth, for the periods indicated, selected statements of operations data:

*(amounts in thousands, except per share data)*

|  | Three Months Ended June 30, 2015 | 2014 | Nine Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $572,301 | $419,899 | $1,521,138 | $1,265,506 |
| Gross profit | 143,798 | 112,603 | 387,410 | 339,191 |
| Gross profit percentage | 25.1% | 26.8% | 25.5% | 26.8% |
| Selling, general and administrative expenses | 66,997 | 55,838 | 178,350 | 160,727 |
| Selling, general and administrative expense as a percentage of revenue | 11.7% | 13.3% | 11.7% | 12.7% |
| Amortization of intangible assets | 3,275 | 1,542 | 6,182 | 4,365 |
| Acquisition-related expenses | 2,459 | — | 4,573 | — |
| Legal and settlement expenses | — | — | — | 600 |
| Operating income | 71,067 | 55,223 | 198,305 | 173,499 |
| Operating margin | 12.4% | 13.2% | 13.0% | 13.7% |
| Interest and other income/(expense), net | (681) | 495 | 439 | 1,304 |
| Income before income taxes | 70,386 | 55,718 | 198,744 | 174,803 |
| Provision for income taxes | 28,127 | 21,290 | 75,108 | 65,559 |
| Effective tax rate | 40.0% | 38.2% | 37.8% | 37.5% |
| Net income | 42,259 | 34,428 | 123,636 | 109,244 |
| Income attributable to noncontrolling interests | (593) | (290) | (1,302) | (40) |
| Net income attributable to MAXIMUS | $41,666 | $34,138 | $122,334 | $109,204 |
| Basic earnings per share attributable to MAXIMUS | $0.63 | $0.50 | $1.86 | $1.61 |
| Diluted earnings per share attributable to MAXIMUS | $0.62 | $0.49 | $1.83 | $1.57 |

The following provides an overview of the significant elements of our Consolidated Statements of Operations. As our business segments have different factors driving revenue growth and profitability, the sections that follow cover these segments in greater detail.

As noted above, the acquisitions of Acentia and Remploy occurred in April 2015. Incremental costs incurred which relate directly to these acquisitions, including legal fees, due diligence, insurance and severance are included above as acquisition-related expenses. The acquisitions also resulted in an additional $1.8 million of intangible amortization expense and $0.7 million of interest expense related to borrowings made to finance the Acentia transaction.

Our year-to-date effective tax rate for the 2015 fiscal year is 37.8%, an increase over the prior year. The acquisition of Acentia and our organic growth has resulted in an increasing share of our income being realized in the United States, which incurs higher tax rates than other jurisdictions in which we operate.

#### Health Services Segment

The Health Services Segment provides a variety of business process services, as well as related consulting services, for state, provincial and national government programs, including Medicaid, CHIP, the ACA, the Health Assessment Advisory Service in the United Kingdom and Health Insurance BC (British Columbia). Acentia’s business has also been integrated into this segment.

*(amounts in thousands)*

|  | Three Months Ended June 30, 2015 | 2014 | Nine Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $439,560 | $305,253 | $1,161,242 | $927,435 |
| Gross profit | 104,593 | 79,532 | 281,895 | 240,906 |
| Operating income | 60,006 | 43,199 | 162,277 | 135,265 |
| Gross profit percentage | 23.8% | 26.1% | 24.3% | 26.0% |
| Operating margin percentage | 13.7% | 14.2% | 14.0% | 14.6% |

Revenue for the three and nine months ended June 30, 2015 increased 44% and 25% compared to the same periods in fiscal year 2014. This movement is a combination of organic revenue increases, acquired revenue and currency fluctuations, summarized below:

*Dollars in Thousands*

*Dollars in Thousands*

|  | Three Months Ended June 30, | Percentage change | Nine Months Ended June 30, | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| Revenue for respective period in fiscal year 2014 | $305,253 |  | $927,435 |  |
| Organic revenue growth | 89,844 | 29.4% | 195,573 | 21.1% |
| Acquired revenue from Acentia | 52,876 | 17.3% | 52,876 | 5.7% |
| Currency effect compared to the prior period | (8,413) | (2.8)% | (14,642) | (1.6)% |
| Revenue for respective period in fiscal year 2015 | $439,560 | 44.0% | 1,161,242 | 25.2% |

Our organic revenue growth is driven by:

- New contracts, including the Health Assessment Advisory Service (“HAAS”) and Fit for Work in the United Kingdom and our contract with the Department of Education in the United States;
- Expansion of our existing work, particularly contracts within the United States, offset by
- An anticipated decline in our federal health appeals business.

The currency declines are caused by the strength of the United States Dollar compared to the same periods in fiscal year 2014. On a constant currency basis, our revenue growth for the three and nine months ended June 30, 2015 would have been 47% and 27%, respectively.

Gross and operating profit margins have declined compared to the prior year. Although many of our domestic change orders have been accretive, the overall margin has been reduced by the following factors.

- The federal appeals business has declined year-over-year.
- With the acquisition of Acentia and the commencement of the HAAS contract, we have a greater share of our customer portfolio that earns income from cost-plus or time-and-materials contracts. These contracts typically offer lower margins in return for lower risk.
- We have several contracts in start-up. We typically see lower profit margins in the early stages of a contract.

We anticipate that our revenue will continue to grow through the final quarter of the fiscal year due to a new contract with an existing client for the U.S. Federal Government and other scope expansion. This benefit will be offset by declines in revenue and profit from the HAAS contract, where challenges in recruiting and retaining healthcare professionals may reduce our performance incentives in this program.

#### Human Services Segment

The Human Services Segment provides national, state and county human services agencies with a variety of business process services and related consulting services for welfare-to-work, child support, higher education and K-12 special education programs. The Remploy business has been integrated into this segment.

*(amounts in thousands)*

|  | Three Months Ended June 30, 2015 | 2014 | Nine Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $132,741 | $114,646 | $359,896 | $338,071 |
| Gross profit | 39,205 | 33,071 | 105,515 | 98,285 |
| Operating income | 16,803 | 13,601 | 46,891 | 43,213 |
| Gross profit percentage | 29.5% | 28.8% | 29.3% | 29.1% |
| Operating margin percentage | 12.7% | 11.9% | 13.0% | 12.8% |

Revenue for the three and nine months ended June 30, 2015 increased 16% and 6.5% compared to the same periods in fiscal year 2014. This movement is a combination of organic revenue increases, acquired revenue and currency fluctuations, summarized below:

*Dollars in Thousands*

*Dollars in Thousands*

|  | Three Months Ended June 30, | Percentage change | Nine Months Ended June 30, | Percentage change |
| --- | ---: | ---: | ---: | ---: |
| Revenue for respective period in fiscal year 2014 | $114,646 |  | $338,071 |  |
| Organic revenue growth | 11,724 | 10.2% | 28,565 | 8.4% |
| Acquired revenue from Remploy | 17,770 | 15.5% | 17,770 | 5.3% |
| Currency effect compared to prior period | (11,399) | (9.9)% | (24,510) | (7.2)% |
| Revenue for respective period in fiscal year 2015 | $132,741 | 15.8% | 359,896 | 6.5% |

Almost all our organic revenue growth driven by our international welfare-to-work contracts has been offset by the detrimental effect of the United States Dollar strength against the Australian Dollar and British Pound. The organic growth was driven by the expansion of existing contracts.

Remploy’s business enjoys higher gross and operating margins than the core Human Services business, resulting in higher overall margins for the business.

In March 2015, we were informed that we have been successful in rebidding and expanding our existing welfare-to-work contract in Australia, starting in July 2015. Although the new contract is anticipated to be profitable, the costs of expanding our operations and the structure of reimbursement under the new arrangement is expected to reduce our fiscal year net income by between $6 million and $9 million. We have incurred some of these costs in the three months ended June 30, 2015, but will incur the majority of these costs in the final quarter of the fiscal year.

### Liquidity and Capital Resources

In April 2015, we utilized $225 million from our revolving credit facility to acquire Acentia, with the balance of the payment being made up with available cash in the United States. In addition, we made some short-term borrowings to cover our immediate working capital requirements. Other outlays, including working capital, capital expenditure, the acquisition of Remploy, repurchases of shares and cash dividends have been funded from our operating cash flows. At June 30, 2015, we have outstanding borrowings of $166.0 million under the credit facility.

Our operating cash inflows are typically driven by our contracts and influenced by payment terms in contracts. For many contracts, including two new projects in the United Kingdom, we are frequently reimbursed up front for the costs of our start-up operations. Although there may be a gap between incurring costs and receiving this reimbursement, we have sufficient funds to cover these costs. Other factors that may cause delays in our realization of customer receipts include customer payments based upon delivering outcomes, which may not correspond with the costs incurred to achieve these outcomes, and short-term payment delays where government budgets are constrained.

Days sales outstanding, or DSO, is a measure of how efficiently we manage the billing and collection of our receivable balances. We calculate DSO by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days. DSO was 64 as of June 30, 2015, compared to 70 as of March 31, 2015. This reduction was driven by improved collection of balances relating to contract start-ups.

Our credit facility allows us to borrow up to $400 million, subject to standard covenants. We anticipate that our cash flows from operations over the course of the next two years should be sufficient to meet our day-to-day requirements, as well as pay our interest and repay the principal on our existing borrowings.

At June 30, 2015, our foreign subsidiaries held approximately 80% of our cash and cash equivalents. We have no requirement or intent to remit this cash to the United States. We consider undistributed earnings of our foreign subsidiaries to be indefinitely reinvested outside of the United States and, accordingly, no U.S. deferred taxes have been recorded with respect to such earnings in accordance with the relevant accounting guidance for income taxes. Should the earnings be remitted as dividends, we may be subject to additional U.S. taxes, net of allowable foreign tax credits. It is not practicable to estimate the amount of any additional taxes which may be payable on the undistributed earnings given the various tax planning alternatives we could employ should we decide to repatriate these earnings in a tax-efficient manner.

#### Cash Flows

*(amounts in thousands)*

| Net cash provided by (used in): | Nine Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: |
| Operating activities | $180,980 | $165,150 |
| Investing activities | (362,373) | (29,886) |
| Financing activities | 109,717 | (79,268) |
| Effect of exchange rate changes on cash and cash equivalents | (4,559) | 1,329 |
| Net increase/(decrease) in cash and cash equivalents | $(76,235) | $57,325 |

Cash provided by operating activities increased 9.6% to $181.0 million for the nine months ended June 30, 2015, compared with the period in the prior fiscal year. This increase is broadly in line with the growth in the overall business.

Cash used in investing activities in for the nine months ended June 30, 2015 included both the acquisitions of Acentia and Remploy, as well as significant investment in our infrastructure in the United States and the United Kingdom. These types of capital investments typically occur in five-to-seven year cycles and include facilities, fixed assets, and upgrades in our telephony and back office data centers. We believe these prudent investments will help drive efficiencies in future periods. This investment will increase our depreciation costs in future periods.

Cash flows from financing activities in the nine months ended June 30, 2015 include the borrowing of $256.0 million from our revolving credit facility, the repayment of $90.0 million and $32.6 million of repurchases of our common stock which occurred in October and November 2014.

The effects of exchange rates reduced our cash balances by $4.6 million in the nine months ended June 30, 2015, principally in balances denominated in the Australian Dollar.

To supplement our statements of cash flows, we calculate free cash flow as follows:

*(amounts in thousands)*

|  | Nine Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: |
| Cash provided by operating activities | $180,980 | $165,150 |
| Purchases of property and equipment | (68,243) | (18,389) |
| Capitalized software costs | (4,924) | (9,177) |
| Free cash flow | $107,813 | $137,584 |

18

### Critical Accounting Policies and Estimates

Our discussion and analysis of financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expenses. On an ongoing basis, we evaluate our estimates including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill and other long-lived assets, and amounts related to contingencies and income tax liabilities. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

We believe that we do not have material off-balance-sheet risk or exposure to liabilities that are not recorded or disclosed in our financial statements. While we have significant operating lease commitments for office space, those commitments are generally tied to the period of performance under related contracts. Additionally, although on certain contracts we are bound by performance bond commitments and standby letters of credit, we have not had any defaults resulting in draws on performance bonds. Also, we do not speculate in derivative transactions.

During the nine months ended June 30, 2015, there were no significant changes to the critical accounting policies we disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended September 30, 2014.

### Non-GAAP measures

Our Discussion and Analysis of Financial Condition and Results of Operations includes measures that are considered non-GAAP numbers. We believe these numbers offer a useful basis for comparing our performance across periods and against our competitors. The presentation of these numbers should not be considered in isolation or as alternatives to revenue growth, net income or cash flows from operations as measures of performance. In addition, these non-GAAP measures, as calculated and presented by us, may not be comparable to other related or similarly titled measures used by other companies. The non-GAAP measures we utilize are as follows:

- Organic revenue growth, which we calculate by excluding the effects of acquisitions and currency fluctuations from our overall revenue growth. We include this measure to assist users of the financial statements assess the performance of our business excluding the effects of acquisitions. We have reconciled this non-GAAP number to related GAAP revenue balances where shown.
- Currency effect on revenue, which we calculate by identifying the difference between international revenues recognized at prevailing exchange rates and what that revenue would have been had the exchange rates prevailing in the comparative period been used. By excluding this revenue fluctuation from our overall revenue growth, we calculate our overall revenue growth on a “constant currency” basis — the revenue we would have reported had exchange rates remained consistent year-over-year. We include this measure to assist users of the financial statements assess the performance of our business excluding the results of foreign exchange fluctuations. We have reconciled this non-GAAP number to the related GAAP revenue balances where shown.
- Free cash flow, which we calculate by deducting fixed asset and software capitalization payments from cash flows from operating activities. We include this measure to assist users of the financial statements in comparing our performance with our competitors and viewing our cash flows without the effects of acquisition expenditures and financing transactions. We have provided a reconciliation of free cash flow where shown.

## Market risk

As filed, 693 characters.

There have been no material changes in the information presented in Item 7A of our Annual Report on Form 10-K for the year ended September 30, 2014.

On April 1, 2015, we borrowed $225 million under our credit facility in connection with our acquisition of Acentia. Our interest rates are based upon our leverage, as defined in our loan agreement, and market interest rates. Accordingly, changes in interest rates will affect our results prospectively. To mitigate our interest rate exposure, we entered into a derivative transaction to fix the interest rate on a portion of this balance. At June 30, 2015, approximately 60% of our outstanding balance was subject to changes in interest rates.

## Controls and procedures

As filed, 1,816 characters.

(a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

With the exception of the matter noted below, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

In April 2015, we acquired both Acentia and Remploy. We have reviewed and identified the existing key controls in these entities and we are in the process of integrating these entities into our existing control environment.

## Risk factors

As filed, 434 characters.

In connection with information set forth in this Form 10-Q, the factors discussed under “Risk Factors” in our Form 10-K for fiscal year ended September 30, 2014 should be considered. The risks included in the Form 10-K could materially and adversely affect our business, financial condition and results of operations. There have been no material changes to the factors discussed in our Form 10-K for the year ended September 30, 2014.

Filed Aug 7, 2015.
Source: SEC EDGAR, the filing index for accession 0001104659-15-057438. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
